To offer more than 230 tests across disease areas
Roche Diagnostics India announced the launch of cobas pure integrated solutions analyser with a more intelligent system particularly suitable for a large number of labs and hospitals operating in India, to make better use of their space and expand their offering of high medical value tests for the benefit of patients.
The new compact analyser combines clinical chemistry, immunoassay and Ion Concentration Measurement (ISE) diagnostic testing on a single platform, helping labs simplify daily operations with limited space and resources. Cobas pure analyser offers the longest onboard stability of reagents allowing labs to expand their test menu.
Built on the latest technology, cobas pure integrated solutions analyser provides labs with an integrated system that focuses on the automation of manual tasks. This reduces the hands-on maintenance time of technicians to just five minutes per day which is 80 per cent less than previous generation systems. This will help improve the productivity of lab personnel whilst also enabling faster delivery of test results and clinical decision-making.
With a footprint of just two square meters, cobas pure analyser is smaller than previous generation systems. It can perform up to 870 tests per hour whilst providing medium-sized labs with access to the full clinical chemistry and immunochemistry assay menu from Roche, which includes more than 230 diagnostic tests across a wide range of disease areas such as critical care, infectious diseases, including COVID-19, women’s health, oncology, cardiology, endocrinology and TDM (Therapeutic Drug Monitoring).
Narendra Varde, MD, Roche Diagnostic India and Neighboring Markets said, “Cobas pure offers diverse critical and complex tests for patients. This consolidation of the test menu would enable labs to speedily perform hundreds of different tests using just a single test tube of blood samples from patients. Through cobas pure, the consolidated test menu can reach beyond metros into a large number of cities where testing menu may be presently limited.”
Furthermore, to ensure simple and effective coordination across healthcare networks, cobas pure integrated solutions provides fully standardized results and operational compatibility with cobas pro integrated solutions – Roche’s latest analyser designed for larger labs. Cobas pure integrated solutions analyser is also fully compatible with the cobas infinity laboratory solution, a software solution designed to optimize information processing from ordering to result management, while intelligently automating the entire sample flow from receipt to storage and bringing meaningful insights for informed decision making.
Cobas pure integrated solutions comes with several innovations including automated maintenance and calibration and completely ready to use reagents that help simplify overall lab operations.
In line with Roche’s continuous focus on driving sustainable practices across business practices and offerings, the plastic generated per test result has been reduced by up to 78 per cent due to smaller reagent pack sizes with a higher number of tests per pack. Roche has been recognised for the twelfth consecutive year, as one of the most sustainable companies in the pharmaceuticals industry by the Dow Jones Sustainability Indices (DJSI).
Also, the required sample volume per test has been reduced on average by 43 per cent compared to previous generation cobas systems.
